These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19221182)

  • 1. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
    Sohaib SA; Cook G; Allen SD; Hughes M; Eisen T; Gore M
    Br J Radiol; 2009 Aug; 82(980):632-9. PubMed ID: 19221182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of whole-body turbo short tau inversion recovery magnetic resonance imaging with panoramic table for detecting bone metastases: comparison with 99MTc-methylene diphosphonate scintigraphy.
    Frat A; Ağildere M; Gençoğlu A; Cakir B; Akin O; Akcali Z; Aktaş A
    J Comput Assist Tomogr; 2006; 30(1):151-6. PubMed ID: 16365592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
    Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
    Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.
    Eustace S; Tello R; DeCarvalho V; Carey J; Wroblicka JT; Melhem ER; Yucel EK
    AJR Am J Roentgenol; 1997 Dec; 169(6):1655-61. PubMed ID: 9393186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
    Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
    J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.
    Engelhard K; Hollenbach HP; Wohlfart K; von Imhoff E; Fellner FA
    Eur Radiol; 2004 Jan; 14(1):99-105. PubMed ID: 12845463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.
    Balliu E; Boada M; Peláez I; Vilanova JC; Barceló-Vidal C; Rubio A; Galofré P; Castro A; Pedraza S
    Clin Radiol; 2010 Dec; 65(12):989-96. PubMed ID: 21070903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of whole body MRI and radioisotope bone scintigram for skeletal metastases detection.
    Chan Y; Chan K; Lam W; Metreweli C
    Chin Med J (Engl); 1997 Jun; 110(6):485-9. PubMed ID: 9594253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of whole-body diffusion-weighted MRI in detecting bone metastasis.
    Del Vescovo R; Frauenfelder G; Giurazza F; Piccolo CL; Cazzato RL; Grasso RF; Schena E; Zobel BB
    Radiol Med; 2014 Oct; 119(10):758-66. PubMed ID: 24638912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2005; 25(6C):4439-44. PubMed ID: 16334123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S; Xue HD; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
    Abe K; Sasaki M; Kuwabara Y; Koga H; Baba S; Hayashi K; Takahashi N; Honda H
    Ann Nucl Med; 2005 Oct; 19(7):573-9. PubMed ID: 16363622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors.
    Ghanem N; Altehoefer C; Kelly T; Lohrmann C; Winterer J; Schäfer O; Bley TA; Moser E; Langer M
    In Vivo; 2006; 20(1):173-82. PubMed ID: 16433049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectral parametric segmentation of contrast-enhanced dual-energy CT to detect bone metastasis: feasibility sensitivity study using whole-body bone scintigraphy.
    Lee YH; Kim S; Lim D; Suh JS; Song HT
    Acta Radiol; 2015 Apr; 56(4):458-64. PubMed ID: 24714734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.
    Kalus S; Saifuddin A
    Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.